whatshot

LNSR   $4.41  5.00% Market Closed

LENSAR Inc
show_chart Advanced Chart of LNSR
Last Events:

2023-08-09 Trend pattern changed from восходящий клин to канал.

2023-08-09 Signal in MACD changed from bearish to bearish weakening. Oscillator MACD is in the negative territory it's lower than the signal line and grows. These factors mean that the falling trend persists, but the growth rate is declining. Last signal: signal line crossed the middle level.

2023-08-09 Trend Power changed from almost flat to slow.

2023-08-06 Signal in Stochastic changed from bearish to bearish weakening. The stochastic indicator is in the lower part of the neutral territory and it heading north. These factors indicate that the upside trend is forming Last signal: main and signal line crossing.

2023-08-06 Signal in RSI changed from bearish recovery to bearish weakening. RSI indicator is in the lower part of the neutral territory and it heading north. These factors indicate that the upside trend is forming Last signal: exit from the overbought zone.

2023-08-04 Trend Power changed from slow to almost flat.

2023-08-03 Trend pattern changed from сужающийся канал to восходящий клин.

2023-08-03 Signal in Stochastic changed from bullish to bearish. The stochastic indicator is in the lower part of the neutral territory and it heading south. These factors indicate that negative dynamics is recovering. Last signal: main and signal line crossing.

Current temperature: 9.49
ST: 0, Cor:

Analyst Recommendations:
Number of estimates 2
Target Price Mean 8.00
Mean unverified/preliminary 8.00 / 8.00
Target Price Low / High 8.00 / 8.00
Median / STD DEV 8.00 / 0.00
Tech Forecasts:
More signals
  < 1M 1-3M > 3M
total Sell Sell Buy
rsi Sell Sell Sell
macd None None None
stoch None None None
ma20 Sell Buy None
ma50 None None None
ma100 Sell Sell ActivelyBuy
Candlestick PatternSept. 18, 2024 Long Legged - consists of a Doji with very long upper and lower shadows. Indicates strong forces balanced in opposition.
ISIN US52634L1089
ceo Mr. Nicholas T. Curtis
Website https://www.lensar.com
LENSAR, Inc., a commercial-stage medical device company, focuses on designing, developing, and marketing a femtosecond laser system for the treatment of cataracts and the management of pre-existing or surgically induced corneal astigmatism. It offers LENSAR Laser System that incorporates a range of proprietary technologies designed to assist the surgeon in obtaining visual outcomes, efficiency, and reproducibility by providing imaging, procedure planning, design, and precision. The company also offers ALLY Adaptive Cataract Treatment System, a platform design to femtosecond laser technology features that enhanced laser capabilities into a single small unit that allows surgeons to perform a femtosecond laser assisted cataract procedure in a single operating room. LENSAR, Inc. was incorporated in 2004 and is headquartered in Orlando, Florida.